The tyrosine kinase adaptor protein FRS2 is oncogenic and amplified in high-grade serous ovarian cancer

Por Luo, Leo Y., Kim, Eejung, Cheung, Hiu Wing, Weir, Barbara A., Dunn, Gavin P., Shen, Rhine R., Hahn, William C.
Publicado no Mol Cancer Res (2014)

Control of Cyclin D1 and Breast Tumorigenesis by the EglN2 Prolyl Hydroxylase

Por Zhang, Qing, Gu, Jinming, Li, Lianjie, Liu, Jiayun, Luo, Biao, Cheung, Hiu-Wing, Boehm, Jesse S., Ni, Min, Geisen, Christoph, Root, David E., Polyak, Kornelia, Brown, Myles, Richardson, Andrea L., Hahn, William C., Kaelin, William G., Bommi-Reddy, Archana
Publicado em 2009

Amplification of CRKL induces transformation and EGFR inhibitor resistance in human non small cell lung cancers

Por Cheung, Hiu Wing, Du, Jinyan, Boehm, Jesse S., He, Frank, Weir, Barbara A., Wang, Xiaoxing, Butaney, Mohit, Sequist, Lecia V., Luo, Biao, Engelman, Jeffrey A., Root, David E., Meyerson, Matthew, Golub, Todd R., Jänne, Pasi A., Hahn, William C.
Publicado em 2011

In vivo multiplexed interrogation of amplified genes identifies GAB2 as an ovarian cancer oncogene

Por Dunn, Gavin P., Cheung, Hiu Wing, Agarwalla, Pankaj K., Thomas, Sapana, Zektser, Yulia, Karst, Alison M., Boehm, Jesse S., Weir, Barbara A., Berlin, Aaron M., Zou, Lihua, Getz, Gad, Liu, Joyce F., Hirsch, Michelle, Vazquez, Francisca, Root, David E., Beroukhim, Rameen, Drapkin, Ronny, Hahn, William C.
Publicado em 2014

Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian cancer target ID4

Por Ren, Yin, Cheung, Hiu Wing, von Maltzhan, Geoffrey, Agrawal, Amit, Cowley, Glenn S., Weir, Barbara A., Boehm, Jesse S., Tamayo, Pablo, Karst, Alison M., Liu, Joyce F., Hirsch, Michelle S., Mesirov, Jill P., Drapkin, Ronny, Root, David E., Lo, Justin, Fogal, Valentina, Ruoslahti, Erkki, Hahn, William C., Bhatia, Sangeeta N.
Publicado em 2012

Highly parallel identification of essential genes in cancer cells

Por Luo, Biao, Cheung, Hiu Wing, Subramanian, Aravind, Sharifnia, Tanaz, Okamoto, Michael, Yang, Xiaoping, Hinkle, Greg, Boehm, Jesse S., Beroukhim, Rameen, Weir, Barbara A., Mermel, Craig, Barbie, David A., Awad, Tarif, Zhou, Xiaochuan, Nguyen, Tuyen, Piqani, Bruno, Li, Cheng, Golub, Todd R., Meyerson, Matthew, Hacohen, Nir, Hahn, William C., Lander, Eric S., Sabatini, David M., Root, David E.
Publicado em 2008

Systematic interrogation of 3q26 identifies TLOC1 and SKIL as cancer drivers

Por Hagerstrand, Daniel, Tong, Alexander, Schumacher, Steven E., Ilic, Nina, Shen, Rhine R., Cheung, Hiu Wing, Vazquez, Francisca, Shrestha, Yashaswi, Kim, So Young, Giacomelli, Andrew O., Rosenbluh, Joseph, Schinzel, Anna C., Spardy, Nicole A., Barbie, David A., Mermel, Craig H., Weir, Barbara A., Garraway, Levi A., Tamayo, Pablo, Mesirov, Jill P., Beroukhim, Rameen, Hahn, William C.
Publicado em 2013

Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer

Por Cheung, Hiu Wing, Cowley, Glenn S., Weir, Barbara A., Boehm, Jesse S., Rusin, Scott, Scott, Justine A., East, Alexandra, Ali, Levi D., Lizotte, Patrick H., Wong, Terence C., Jiang, Guozhi, Hsiao, Jessica, Mermel, Craig H., Getz, Gad, Barretina, Jordi, Gopal, Shuba, Tamayo, Pablo, Gould, Joshua, Tsherniak, Aviad, Stransky, Nicolas, Luo, Biao, Ren, Yin, Drapkin, Ronny, Bhatia, Sangeeta N., Mesirov, Jill P., Garraway, Levi A., Meyerson, Matthew, Lander, Eric S., Root, David E., Hahn, William C.
Publicado em 2011